PharmaCyte Biotech Inc.

PharmaCyte Biotech’s $15 Million Follow-On Public Offering

By Martina Bellini

Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech, Inc. on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America. North America Legal Chronicle. September 2, 2021

PharmaCyte’s $70 Million Rights Offering

By Martina Bellini

Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Bloomberg’s Expansion Lease with SL Green Realty

Beacon Power Services’ Series A Raising

Benedict Realty Group’s $46.5 Million Acquisition of Multifamily Portfolio in Queens

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

360 Energy Solar’s US$22 Million Green Notes Issuance

Ardian’s Acquisition of a Majority Interest in Vista Vision

Pivotal’s Acquisition of Security Plus Limited

Savino Del Bene S.p.A.’s Acquisition of Seabridge Transport GmbH

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Afcons Infrastructure’s $645 Million IPO

Godavari Biorefineries Limited’s Initial Public Offering

Synthimed Labs’ Acquisition of Ind Swift Laboratories

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

PharmaCyte Biotech’s $15 Million Follow-On Public Offering

Standard 1 Year Membership Required

PharmaCyte’s $70 Million Rights Offering

Standard 1 Year Membership Required